España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Blue Water Ventures Intl
BWVI
OTCEM
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.00040
At close: Jan 21, 10:34 AM EDT
Get Report
Comment
Blue Water Ventures Intl (BWVI) Forecast
News
Earnings
Blue Water Ventures Intl (BWVI) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Blue Water Ventures Intl (OTC:BWVI) Stock
Blue Water Ventures Intl Stock (OTC: BWVI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, October 30, 2024
WHO Expands Emergency Use List For Mpox Diagn...
Benzinga Newsdesk
Friday, August 30, 2024
WHO Chief Tedros Says Mpox Vaccines Could Be ...
Benzinga Newsdesk
WHO Chief Tedros Says Received First Expressi...
Benzinga Newsdesk
Thursday, August 22, 2024
WHO: Côte d'Ivoire Reports First Cases Of Cla...
Benzinga Newsdesk
Tuesday, August 13, 2024
I Saw Trillions Of Atoms In My Hand Vibrating At A Certain Frequency, Says Zappy Zapolin Describing His First Psychedelics Experience
Nina Zdinjak
Wednesday, March 06, 2024
Psychedelics 2024: Veterans Blessing, Mental Health Paradigm Shift, Providers Training, Ketamine-MDMA Bonds & More
Lara Goldstein
Thursday, February 29, 2024
Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream'
Lara Goldstein
Sunday, September 03, 2023
Treating PTSD Topically & Directly To The Brain? Psychedelics Delivery Company Poised For Major Breakthrough
Maureen Meehan
Friday, June 23, 2023
Video: 'Moms On Mushrooms Are Gonna Change The Whole Society,' Says Zappy Zapolin Before Presenting Rick Doblin Award
Javier Hasse
Friday, May 12, 2023
EXCLUSIVE: Lessons From Psychedelics Markets Through Business, Legal And Reciprocity Lenses
Lara Goldstein
Wednesday, May 03, 2023
Zappy Zapolin Talks Psychedelics And Breakthrough Delivery Methods: The Future Has Arrived And It's Awesome
Maureen Meehan
Tuesday, April 11, 2023
Psyched: MDMA Therapy Advances With FDA, Alternatives For Alcohol Addiction, Prince Harry In The Spotlight And More
Lara Goldstein
Wednesday, April 05, 2023
This Groundbreaking Ketamine Topical Cream Is Capturing Rick Doblin's Attention
Javier Hasse
Monday, April 03, 2023
What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry
Javier Hasse
Monday, March 27, 2023
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
Lara Goldstein
Wednesday, March 22, 2023
PTSD Treatment Is On The Horizon: A New Cream Could Be The Answer
Lara Goldstein
Monday, March 13, 2023
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
Lara Goldstein
Wednesday, March 08, 2023
Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person
Lara Goldstein
Tuesday, March 07, 2023
Benzinga's Psychedelics Capital Conference: Meet An Unrivaled Group Of Advisors And Fund Partners
Lara Goldstein
Thursday, February 16, 2023
Novel Ketamine Topical Cream To Treat PTSD Gets First In-Human Trials
Lara Goldstein
Thursday, January 26, 2023
Zappy Zapolin's Psycheceutical Files Patent, Hopes Ketamine Topical Can Treat PTSD
Lara Goldstein
Tuesday, October 04, 2022
Zappy Zapolin Of Psycheceutical Bioscience Joins The Benzinga Psychedelics Advisory Council: What You Need To Know
Javier Hasse
Tuesday, August 16, 2022
Psychedelic Acquisition: Psycheceutical To Buy Majority Equity Stake In Maryland R&D Company
Lara Goldstein
Tuesday, May 10, 2022
EXCLUSIVE: Kevin Harrington Becomes The Latest 'Shark Tank' Judge To Enter The Psychedelics Space
Natan Ponieman
Wednesday, March 02, 2022
Researcher Portrayed In Hollywood Movie By Alec Baldwin Joins Psychedelics Company
Natan Ponieman
Friday, December 27, 2019
Stocks That Hit 52-Week Lows On Friday
Lisa Levin
Thursday, November 21, 2019
Stocks That Hit 52-Week Lows On Thursday
Lisa Levin
Friday, November 01, 2019
Stocks That Hit 52-Week Lows On Friday
Lisa Levin
